Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Left Out Of $80M For Stopping Consumer Product Fraud In Latest US COVID-19 Relief Act

Mar 17 2021

• By Malcolm Spicer

Related Content

US Pandemic Relief Package Delivers OTC Industry Regulatory Wishes, Supplement Business Hopes

Mar 27 2020

Congress Gives FDA Authority To Destroy Counterfeit Devices Found In Imports

Dec 18 2020

Natural Products Sector Will Try Again With $310Bn More Available For Small Business PPP Loans

Apr 25 2020

COVID-19 False Advertising Symptoms In US Exceed FTC’s Prognosis For Number, Variety

Sep 04 2020

US COVID-19 Fraud: Warnings Target ‘Corona Destroyer’ Tea, 600-Use Iodine Hand Wipe

Mar 17 2021

Additional Topics

International United States Coronavirus COVID-19 Legislation FDA Commercial Compliance Dietary Supplements Distribution E-Commerce Enforcement Manufacturing Regulation Safety Consumer

More from Legislation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window